Login / Signup

Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities.

Jannis KountourasApostolis PapaefthymiouStergios A PolyzosEvangelos KazakosDimitrios TzilvesMaria TouloumtziDimitrios ChatzopoulosMaria Tzitiridou-ChatzopoulouChristos LiatsosChristos ZavosJohn KavaliotisHasan KulaksizMichael Doulberis
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • early onset
  • bone mineral density
  • drug induced
  • liver fibrosis